Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Teva
Merck
Baxter
Boehringer Ingelheim
Fuji
Federal Trade Commission
Queensland Health
Chinese Patent Office

Generated: September 20, 2018

DrugPatentWatch Database Preview

MINOCIN Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Drug patent expirations by year for MINOCIN
Pharmacology for MINOCIN
Ingredient-typeTetracyclines
Drug ClassTetracycline-class Drug
Medical Subject Heading (MeSH) Categories for MINOCIN
Synonyms for MINOCIN
(2E,4S,4aR,5aS,12aR)-2-(amino-hydroxy-methylidene)-4,7-bis(dimethylamino)-10,11,12a-trihydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3 ,12-trione
(2E,4S,4AS,5AR,12AS)-2-[AMINO(HYDROXY)METHYLIDENE]-4,7-BIS(DIMETHYLAMINO)-10,11,12A-TRIHYDROXY-1,2,3,4,4A,5,5A,6,12,12A-DECAHYDROTETRACENE-1,3,12-TRIONE
(2E,4S,4aS,5aR,12aS)-2-[amino(hydroxy)methylidene]-4,7-bis(dimethylamino)-10,11,12a-trihydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z,4S,4aS,5aR,12aS)-2-[amino(hydroxy)methylidene]-4,7-bis(dimethylamino)-10,11,12a-trihydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(4S,4aS,5aR,12aS)-2-[amino(hydroxy)methylidene]-4,7-bis(dimethylamino)-10,11,12a-trihydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE
(4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide
(4S,4aS,5aR,12aS)4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxonaphthacene-2-carboxamide;(4S,4aS,5aR,12aS)4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydro
10118-90-8
1071761-03-9
13614-98-7 (mono-hydrochloride)
1371-EP2269978A2
1371-EP2269985A2
1371-EP2269991A2
1371-EP2272832A1
1371-EP2284150A2
1371-EP2284151A2
1371-EP2284152A2
1371-EP2284153A2
1371-EP2284155A2
1371-EP2284156A2
1371-EP2284164A2
1371-EP2287140A2
1371-EP2287148A2
1371-EP2287150A2
1371-EP2289871A1
1371-EP2292590A2
1371-EP2292612A2
1371-EP2295402A2
1371-EP2295419A2
1371-EP2295426A1
1371-EP2295427A1
1371-EP2298732A1
1371-EP2301534A1
1371-EP2301912A2
1371-EP2301913A1
1371-EP2301914A1
1371-EP2301916A2
1371-EP2305637A2
1371-EP2308832A1
1371-EP2308863A1
1371-EP2311451A1
1371-EP2311796A1
1371-EP2311797A1
1371-EP2311798A1
1371-EP2311799A1
1371-EP2316450A1
146440-73-5
17175-40-5
18M908
2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S-(4alpha,4aalpha,5aalpha,12aalpha))-
2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)-
24058-90-0
4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide
7-Dimethylamino-6-demethyl-6-deoxytetracycline
AB00053501_04
AB00053501_05
AB00053501-03
AC1L2NSN
AC1NQXWM
AC1NSG0A
AJ-65483
AK322058
Akamin
Aknemin
AKOS015969674
Alti-Minocycline
AM20090714
API0003397
Apo-Minocycline
Arestin
BCBcMAP01_000027
BCP9000928
BDBM50103599
Bio-0062
Borymycin
BRN 3077644
BSPBio_002035
C07225
C23H27N3O7
CAS-10118-90-8
CHEBI:50694
CHEMBL1434
CHEMBL259172
CL 59806
CRL-1605 & Minocycline
D05045
D08LTU
DB01017
DivK1c_000450
DSSTox_CID_25033
DSSTox_GSID_45033
DSSTox_RID_80650
DTXSID1045033
DYKFCLLONBREIL-KVUCHLLUSA-N
Dynacin
FT-0628949
FYY3R43WGO
Gen-Minocycline
HMS2090D03
HSDB 3130
IDI1_000450
J-500789
KBio1_000450
KBio2_001447
KBio2_004015
KBio2_006583
KBio3_001535
KBioGR_000583
KBioSS_001447
Klinomycin
KSC-12-231B
KUC106429N
Lactoferrin B & Minocycline
Lactoferrin H & Minocycline
LMPK07000002
LS-93850
MINO
Mino-Tabs
Minociclina
Minociclina [INN-Spanish]
minociclinum
Minocin (Hydrochloride)
Minocin (TN)
Minocline
Minocyclin
minocycline
Minocycline (USAN/INN)
Minocycline [USAN:BAN:INN]
Minocycline [USAN:INN:BAN]
Minocycline Monohydrochloride
Minocyclinum
Minocyclinum [INN-Latin]
Minocyn
Minoderm
Minoz
MIY
MolPort-020-005-814
NCGC00178854-01
NCGC00183044-01
NCGC00188954-01
NINDS_000450
Novo-Minocycline
NSC 141993
NSC141993
PL009220
PL045106
Prestwick0_000315
Prestwick1_000315
Prestwick2_000315
SBI-0051449.P003
SCHEMBL16681149
SCHEMBL24315
SCHEMBL4042
Sebomin
SMP1_000191
Solodyn
SPBio_000974
SPBio_002529
Spectrum_000967
Spectrum2_001047
Spectrum3_000508
Spectrum4_000062
Spectrum5_001293
Tox21_113643
Tri-minocycline
UNII-FYY3R43WGO
Vectrin
Vectrin (Hydrochloride)
ZINC100409820
ZINC14879992
ZINC4019704

US Patents and Regulatory Information for MINOCIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Precision Dermat MINOCIN minocycline hydrochloride CAPSULE;ORAL 050649-001 May 31, 1990 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Rempex Pharms MINOCIN minocycline hydrochloride INJECTABLE;INJECTION 050444-001 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Triax Pharms MINOCIN minocycline hydrochloride CAPSULE;ORAL 050315-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Rempex Pharms MINOCIN minocycline hydrochloride INJECTABLE;INJECTION 050444-001 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Non-Orange Book US Patents for MINOCIN

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,744,179 Tetracycline compositions ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Teva
Merck
Baxter
Boehringer Ingelheim
Fuji
Federal Trade Commission
Queensland Health
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.